share_log

SVB Leerink Maintains Outperform on Pardes Biosciences, Lowers Price Target to $9

Benzinga Real-time News ·  Jan 27, 2023 06:49

SVB Leerink analyst Roanna Ruiz maintains Pardes Biosciences (NASDAQ:PRDS) with a Outperform and lowers the price target from $12 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment